Immunogenicity of biosimilar therapies for psoriasis in head-to-head trials.

Saved in:
Bibliographic Details
Title: Immunogenicity of biosimilar therapies for psoriasis in head-to-head trials.
Authors: Smith LR; University of South Florida Health, Department of Internal Medicine, Tampa, Florida; Department of Dermatology, Center for Dermatology Research, Wake Forest School of Medicine, Winston-Salem, North Carolina., Feldman SR; Department of Dermatology, Center for Dermatology Research, Wake Forest School of Medicine, Winston-Salem, North Carolina; Department of Pathology, Wake Forest School of Medicine, Winston-Salem, North Carolina; Department of Social Sciences & Health Policy, Wake Forest School of Medicine, Winston-Salem, North Carolina; Department of Dermatology, University of Southern Denmark, Odense, Denmark. Electronic address: steven.feldman@advocatehealth.org.
Source: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2026 Apr; Vol. 94 (4), pp. 1306-1308. Date of Electronic Publication: 2025 Dec 20.
Publication Type: Journal Article
Journal Info: Publisher: Mosby Country of Publication: United States NLM ID: 7907132 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6787 (Electronic) Linking ISSN: 01909622 NLM ISO Abbreviation: J Am Acad Dermatol Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Description
ISSN:1097-6787
DOI:10.1016/j.jaad.2025.12.061